In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Choseido Pharmaceutical Co. Ltd.

Division of Mitsubishi Chemical Holdings Corp.
www.choseido.com

Latest From Choseido Pharmaceutical Co. Ltd.

Mitsubishi Tanabe Cuts Ties with Four-year Generics Subsidiary, But Sales Goals Remain

Mitsubishi Tanabe sold all shares of its Choseido Pharmaceutical subsidiary after not meeting expectations, and must now reassess its generics strategy.

BioPharmaceutical Japan

To Fill Pipeline Gaps, Astellas Narrows Focus And Takeda Spreads A Wider Net: Japan Earnings Roundup

PharmAsia News takes a closer look at pipeline updates from Japan’s two largest pharma companies.

BioPharmaceutical Japan

To Fill Pipeline Gaps, Astellas Narrows Focus And Takeda Spreads A Wider Net: Japan Earnings Roundup (Part 1)

In part one of this roundup of the Japanese pharma earnings season, PharmAsia News takes a closer look at the pipeline updates from the country's two largest pharma companies.

BioPharmaceutical Japan
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register